Ligand Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Ligand Pharmaceuticals Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Ligand Pharmaceuticals Inc Strategy Report

  • Understand Ligand Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Ligand Pharmaceuticals Inc: Overview

Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help biopharmaceutical companies in the discovery and development of medicines. Its major research technologies include formulation science, structure-based drug design, antibody discovery technologies and liver targeted pro-drug technologies, which assist pharmaceutical companies in securing approval for prescription drugs. Its technologies and research capabilities contributed to the development of a diversified portfolio of biotechnology and pharmaceutical products for the inflammatory, respiratory central nervous system, oncology, ophthalmology, hematology, musculoskeletal disorder, and osteoporosis, among others. Ligand also offers late-stage development, regulatory management, and commercialization support in partnership with other pharmaceutical companies. Ligand is headquartered in San Diego, California, the US.

Gain a 360-degree view of Ligand Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Ligand Pharmaceuticals Inc and make more informed decisions for your business Find out more
Headquarters United States of America

Address 3911 Sorrento Valley Blvd, Suite 110, San Diego, California, 92121


Telephone 1 858 5507500

No of Employees 58

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange LGND (NASD)

Revenue (2023) $131.3M -33.1% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 256.3% (2023 vs 2022)

Market Cap* $1.3B

Net Profit Margin (2023) XYZ 333.7% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Ligand Pharmaceuticals Inc premium industry data and analytics

320+

Pipeline Drugs

Identify which of Ligand Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

170+

Clinical Trials

Determine Ligand Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

14+

Catalyst Calendar

Proactively evaluate Ligand Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

7

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Marketed Drugs

Understand Ligand Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Ligand Pharmaceuticals Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Technologies: -
Captisol (Uniquely Modified Cyclodextrin) OmniRat
OmniAb (Therapeutic Antibody Platform) OmniAb
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Ligand Pharmaceuticals Inc portfolio and identify potential areas for collaboration Understand Ligand Pharmaceuticals Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Regulatory Approval In January, the company's Zelsuvmi (berdazimer topical gel, 10.3%) received approval from the US Food and Drug Administration for molluscum contagiosum.
2023 Contracts/Agreements In December, the company expanded its partnership with Palvella Therapeutics to accelerate Phase 3 development of QTORIN rapamycin for the treatment of Microcystic Lymphatic Malformations.
2023 Acquisitions/Mergers/Takeovers In November, the company acquired Tolerance Therapeutics, Inc.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Ligand Pharmaceuticals Inc Gilead Sciences Inc Regeneron Pharmaceuticals Inc TransGenic Inc Atara Biotherapeutics Inc
Headquarters United States of America United States of America United States of America Japan United States of America
City San Diego Foster City Tarrytown Fukuoka-Shi Thousand Oaks
State/Province California California New York Fukuoka California
No. of Employees 58 18,000 13,450 236 308
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
John W. Kozarich, Ph.D. Chairman Executive Board 2007 73
Todd C. Davis Chief Executive Officer Executive Board 2022 62
Tavo Espinoza Chief Financial Officer Senior Management 2022 -
Matthew Korenberg President; Chief Operating Officer Senior Management 2022 -
Andrew Reardon Chief Legal Officer Senior Management 2022 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Ligand Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Ligand Pharmaceuticals Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward